Market Cap
$3.42T
+2.4% today
Sector & Industry
Healthcare
Pharmaceuticals
SEC Filings
138
Total filings on record
Last Filing
Feb 1, 2026
8-K — Board of Directors Update
Showing 15 filings
| Form Type | Filed Date | Accepted | Description | Accession | Actions |
|---|---|---|---|---|---|
| 10-Q | Feb 1, 2026 | Feb 1, 2026 | Quarterly Report for period ended June 2025 | 0002079495-26-179910 | |
| S-1 | Dec 28, 2025 | Dec 28, 2025 | Registration Statement | 0002079495-26-611891 | |
| DEF 14A | Dec 2, 2025 | Dec 2, 2025 | Definitive Proxy Statement for Annual Meeting | 0002079495-26-545408 | |
| Form 4 | Nov 4, 2025 | Nov 4, 2025 | Statement of Changes - Michael Brown | 0002079495-26-450254 | |
| 10-Q | Oct 12, 2025 | Oct 12, 2025 | Quarterly Report for period ended January 2025 | 0002079495-26-653263 | |
| Form 4 | Sep 7, 2025 | Sep 7, 2025 | Statement of Changes - James Williams | 0002079495-26-260003 | |
| 13F | Aug 13, 2025 | Aug 13, 2025 | Institutional Investment Manager Holdings Report | 0002079495-26-205636 | |
| 8-K | Jul 9, 2025 | Jul 9, 2025 | Current Report - Material Event Disclosure | 0002079495-26-164569 | |
| 13F | Jun 16, 2025 | Jun 16, 2025 | Institutional Investment Manager Holdings Report | 0002079495-26-917559 | |
| 8-K | May 17, 2025 | May 17, 2025 | Current Report - Material Event Disclosure | 0002079495-26-137624 | |
| 10-K | Apr 23, 2025 | Apr 23, 2025 | Annual Report for fiscal year ended September 2025 | 0002079495-25-234005 | |
| 10-K | Mar 22, 2025 | Mar 22, 2025 | Annual Report for fiscal year ended September 2025 | 0002079495-25-158092 | |
| 13F | Feb 22, 2025 | Feb 22, 2025 | Institutional Investment Manager Holdings Report | 0002079495-25-440816 | |
| Form 4 | Jan 25, 2025 | Jan 25, 2025 | Statement of Changes - Michael Brown | 0002079495-25-526128 | |
| 10-K | Dec 30, 2024 | Dec 30, 2024 | Annual Report for fiscal year ended January 2025 | 0002079495-25-230191 |